219 related articles for article (PubMed ID: 21196896)
41. Adefovir dipivoxil therapy in liver transplant recipients for recurrence of hepatitis B virus infection despite lamivudine plus hepatitis B immunoglobulin prophylaxis.
Akyildiz M; Karasu Z; Zeytunlu M; Aydin U; Ozacar T; Kilic M
J Gastroenterol Hepatol; 2007 Dec; 22(12):2130-4. PubMed ID: 18031370
[TBL] [Abstract][Full Text] [Related]
42. Prophylaxsis against recurrance of hepatitis B virus after liver transplantation: a retrospective analysis spanning 20 years.
Yilmaz N; Shiffman ML; Todd Stravitz R; Sterling RK; Luketic VA; Sanyal AJ; Maluf D; Coterell A; Posner MP; Fisher RA
Liver Int; 2008 Jan; 28(1):72-8. PubMed ID: 17983429
[TBL] [Abstract][Full Text] [Related]
43. Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin.
Terrault NA; Zhou S; Combs C; Hahn JA; Lake JR; Roberts JP; Ascher NL; Wright TL
Hepatology; 1996 Dec; 24(6):1327-33. PubMed ID: 8938155
[TBL] [Abstract][Full Text] [Related]
44. Failure of hepatitis B vaccination with conventional HBsAg vaccine in patients with continuous HBIG prophylaxis after liver transplantation.
Rosenau J; Hooman N; Hadem J; Rifai K; Bahr MJ; Philipp G; Tillmann HL; Klempnauer J; Strassburg CP; Manns MP
Liver Transpl; 2007 Mar; 13(3):367-73. PubMed ID: 17318859
[TBL] [Abstract][Full Text] [Related]
45. Liver transplantation for chronic hepatitis B infection with the use of combination lamivudine and low-dose hepatitis B immune globulin.
Yoshida EM; Erb SR; Partovi N; Scudamore CH; Chung SW; Frighetto L; Eggen HJ; Steinbrecher UP
Liver Transpl Surg; 1999 Nov; 5(6):520-5. PubMed ID: 10545541
[TBL] [Abstract][Full Text] [Related]
46. [The study of the different medicating ways and the formula for intravenous loading dosage of hepatitis B immunoglobulin in liver transplantation].
Niu YJ; Zang YJ; Chen XG; Li W; Zhu XD; Liu Y; Wei ZY; Zhang ZT; Wang Y; Shen ZY
Zhonghua Wai Ke Za Zhi; 2006 Nov; 44(21):1444-7. PubMed ID: 17349164
[TBL] [Abstract][Full Text] [Related]
47. Escape hepatitis B virus mutations in recipients of antibody to hepatitis B core antigen-positive liver grafts receiving hepatitis B immunoglobulins.
Roche B; Roque-Afonso AM; Sebagh M; Delvart V; Duclos-Vallee JC; Castaing D; Samuel D
Liver Transpl; 2010 Jul; 16(7):885-94. PubMed ID: 20583085
[TBL] [Abstract][Full Text] [Related]
48. Hepatitis B prophylaxis in living donor liver transplantation: single center experience.
Yaprak O; Dayangac M; Balci D; Bas K; Yuzer Y; Tokat Y
Hepatogastroenterology; 2010; 57(102-103):1178-82. PubMed ID: 21410054
[TBL] [Abstract][Full Text] [Related]
49. Nucleoside plus nucleotide analogs and cessation of hepatitis B immunoglobulin after liver transplantation in chronic hepatitis B is safe and effective.
Wesdorp DJ; Knoester M; Braat AE; Coenraad MJ; Vossen AC; Claas EC; van Hoek B
J Clin Virol; 2013 Sep; 58(1):67-73. PubMed ID: 23880162
[TBL] [Abstract][Full Text] [Related]
50. Response to an experimental HBV vaccine permits withdrawal of HBIg prophylaxis in fulminant and selected chronic HBV-infected liver graft recipients.
Stärkel P; Stoffel M; Lerut J; Horsmans Y
Liver Transpl; 2005 Oct; 11(10):1228-34. PubMed ID: 16184571
[TBL] [Abstract][Full Text] [Related]
51. Personalized subcutaneous administration of hepatitis B surface antibodies without nucleos(t)ide analogs for patients at risk of renal failure after liver transplantation: a prospective single center cohort study.
Bielen R; Robaeys G; Schelfhout S; Monbaliu D; Van der Merwe S; Pirenne J; Nevens F
Transpl Int; 2018 May; 31(5):503-509. PubMed ID: 29359868
[TBL] [Abstract][Full Text] [Related]
52. Tenofovir-emtricitabine therapy for the prevention of hepatitis B recurrence in four patients after liver transplantation.
McGonigal KH; Bajjoka IE; Abouljoud MS
Pharmacotherapy; 2013 Sep; 33(9):e170-6. PubMed ID: 23744810
[TBL] [Abstract][Full Text] [Related]
53. Anti-HBs response to hepatitis B immunoglobulin prophylaxis in liver transplant recipients.
Varghese J; Reddy MS; Cherian T; Vijaya S; Jayanthi V; Rela M
Indian J Gastroenterol; 2014 May; 33(3):226-30. PubMed ID: 24760685
[TBL] [Abstract][Full Text] [Related]
54. Evolving strategies to prevent HBV recurrence.
Roche B; Samuel D
Liver Transpl; 2004 Oct; 10(10 Suppl 2):S74-85. PubMed ID: 15382222
[TBL] [Abstract][Full Text] [Related]
55. Hepatocellular carcinoma is associated with an increased risk of hepatitis B virus recurrence after liver transplantation.
Faria LC; Gigou M; Roque-Afonso AM; Sebagh M; Roche B; Fallot G; Ferrari TC; Guettier C; Dussaix E; Castaing D; Brechot C; Samuel D
Gastroenterology; 2008 Jun; 134(7):1890-9; quiz 2155. PubMed ID: 18424269
[TBL] [Abstract][Full Text] [Related]
56. The long-term efficacy of nucleos(t)ide analog plus a year of low-dose HBIG to prevent HBV recurrence post-liver transplantation.
Tanaka T; Benmousa A; Marquez M; Therapondos G; Renner EL; Lilly LB
Clin Transplant; 2012; 26(5):E561-9. PubMed ID: 23061767
[TBL] [Abstract][Full Text] [Related]
57. Low-dose anti-hepatitis B immunoglobulin regimen as prophylaxis for hepatitis B recurrence after liver transplantation.
Lee WC; Chou HS; Wu TH; Cheng CH; Lee CF; Wang YC; Wu TJ; Chan KM
Transpl Infect Dis; 2019 Dec; 21(6):e13190. PubMed ID: 31587427
[TBL] [Abstract][Full Text] [Related]
58. Hepatitis B immunoglobulin discontinuation followed by hepatitis B virus vaccination: A new strategy in the prophylaxis of hepatitis B virus recurrence after liver transplantation.
Sánchez-Fueyo A; Rimola A; Grande L; Costa J; Mas A; Navasa M; Cirera I; Sánchez-Tapias JM; Rodés J
Hepatology; 2000 Feb; 31(2):496-501. PubMed ID: 10655276
[TBL] [Abstract][Full Text] [Related]
59. Prevention of recurrent hepatitis B post-liver transplantation.
Lok AS
Liver Transpl; 2002 Oct; 8(10 Suppl 1):S67-73. PubMed ID: 12362302
[TBL] [Abstract][Full Text] [Related]
60. Safety and efficacy of subcutaneous hepatitis B immunoglobulin after liver transplantation: an open single-arm prospective study.
Di Costanzo GG; Lanza AG; Picciotto FP; Imparato M; Migliaccio C; De Luca M; Scuderi V; Tortora R; Cordone G; Utech W; Calise F
Am J Transplant; 2013 Feb; 13(2):348-52. PubMed ID: 23137160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
